The authors report no conflicts of interest related to the subject of this work. MET has received compensation from AstraZeneca, Bristol-Myers Squibb, Cephalon, Cyberonics, Eli Lilly & Co., GlaxoSmithKline, Janssen Pharmaceutica, MedAvante, Neuronetics, Novartis, Organon, Sepracor, Shire US, Supernus Pharmaceuticals, Wyeth Pharmaceuticals, Sanofi-aventis, Jones Day (Wyeth Litigation), Phillips Lytle (GlaxoSmithKline Litigation), American Psychiatric Publishing, Guilford Publications, and Herald House; and reports equity holdings in MedAvante, Inc., but has received no financial compensation to date. RH has received compensation from Eli Lilly & Co., GlaxoSmithKline, Wyeth Pharmaceuticals, and Abbott. DAL has received compensation from NIMH through Kelly Services, Inc. (a contracting agency); from Yale University through investigator Dr. Alex Neumeister; and from UCLA through a grant from the Stanley Foundation and administered by Dr. Lori Altshuler. EF has received compensation from Pfizer, Eli Lilly & Co., Novartis, Servier, Forest Research Institute, the Pittsburgh Foundation, Guilford Press, and Lundbeck. DJK has received compensation from Eli Lilly & Co., Forest Pharmaceuticals, Pfizer, Solvay/Wyeth Pharmaceuticals, and Servier Amerique.
Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms
Version of Record online: 18 NOV 2008
© 2008 The Authors. Journal compilation © 2008 Blackwell Munksgaard
Volume 10, Issue 8, pages 856–866, December 2008
How to Cite
Mallinger, A. G., Thase, M. E., Haskett, R., Buttenfield, J., Luckenbaugh, D. A., Frank, E., Kupfer, D. J. and Manji, H. K. (2008), Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms. Bipolar Disorders, 10: 856–866. doi: 10.1111/j.1399-5618.2008.00636.x
- Issue online: 18 NOV 2008
- Version of Record online: 18 NOV 2008
- Received 9 August 2007, revised and accepted for publication 29 April 2008
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.